Global burden of hepatitis C: considerations for healthcare providers in the United States

An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases Jg. 55 Suppl 1; S. S10
Hauptverfasser: Averhoff, Francisco M, Glass, Nancy, Holtzman, Deborah
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 15.07.2012
Schlagworte:
Disease Eradication - methods
Global Health
Health Personnel - organization & administration
Health Personnel - standards
Hepacivirus - pathogenicity
Hepatitis C - blood
Hepatitis C - epidemiology
Hepatitis C - prevention & control
Hepatitis C - virology
Humans
Liver Cirrhosis - epidemiology
Liver Cirrhosis - prevention & control
Liver Cirrhosis - virology
Liver Neoplasms - epidemiology
Liver Neoplasms - prevention & control
Liver Neoplasms - virology
Prevalence
Preventive Health Services - organization & administration
Preventive Health Services - standards
Risk Factors
United States - epidemiology
Viral Load
United States
ISSN:1537-6591, 1537-6591
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings. Hepatitis C prevention, care, and treatment programs must recognize country-specific epidemiology, which varies by setting and level of economic development. Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCV infection is endemic and for counseling patients who travel to these countries. Countries with a high burden of HCV infection also would benefit from establishing comprehensive prevention, care, and treatment programs.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1537-6591
1537-6591
DOI:10.1093/cid/cis361